Infliximab as a treatment for recalcitrant pyoderma gangrenosum.
Singh
M
M
Andrew
S M
SM
Lear
J T
JT
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D012008:Recurrence
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab